The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the top two: cholesterol ...
Jul 25, 2011
4
0
If the cost of your generic prescription drug has risen, it may be due to a lack of competition among drug manufacturers, according to a University of Florida College of Pharmacy study.
Jul 3, 2017
0
2
Over the last 20 years, the number of hospital emergency departments in nonrural areas in the U.S. has declined by nearly 30 percent, with for-profit ownership, location in a competitive market, low profit margin and safety-net ...
May 17, 2011
1
0
When bidding in a competitive market, brains use a special type of heuristic to adjust the price depending on the success of previous attempts to buy goods. Moreover, this learning mechanism involves not only the cerebral ...
Sep 18, 2019
0
2
Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's ...
Jul 30, 2019
0
4
(Medical Xpress)—Certificate of Need, a form of state government regulation designed to keep mortality rates and health care costs down, appears to do neither for heart bypass surgery, according to a health economics researcher ...
Oct 3, 2012
0
0
(HealthDay)—The final rule of the Department of Health and Human Services (HHS) Notice of Benefit and Payment Parameters for 2014, which expands on existing standards, has been released.
Mar 16, 2013
0
0
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Aug 7, 2012
0
0
Despite the legalization of cannabis sales in Canada and many U.S. states, an illegal market still exists. A new study in the Journal of Studies on Alcohol and Drugs suggests that higher prices and inconvenience associated ...
May 24, 2022
0
1
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Nov 1, 2012
0
0
